Search

The rapid integration of artificial intelligence (AI) into healthcare analytics has amplified the need for robust frameworks that govern secondary use of genomic and clinical data while prioritizing patient consent and policy compliance. This conceptual manuscript introduces a novel policy-constrained access control framework designed to facilitate consent-aware analytics in genomic-clinical environments. By embedding dynamic consent mechanisms into data access pipelines, the framework ensures that secondary data utilization adheres to ethical, legal, and institutional policies, mitigating risks associated with unauthorized reuse. We synthesize recent literature on data sharing, privacy protections, and genomic informatics to underscore the framework’s theoretical foundations. Key components include layered access orchestration, policy-enforced query resolution, and feedback loops for consent revocation monitoring. Conceptual formulas are presented to interpret risk propagation in access chains and governance load under varying policy constraints. The architecture promotes interoperability between genomic repositories and clinical systems, fostering trustworthy AI-driven insights without empirical validation. Implications for healthcare stakeholders emphasize enhanced data stewardship, reduced privacy breaches, and scalable secondary analytics. This work advances conceptual discourse on AI-enabled healthcare systems by proposing a governance-centric infrastructure that balances innovation with patient autonomy in secondary data contexts.